Risk factors

The SynCardia TAH drives nearly all near-term revenue, concentrating commercial risk in one product.

Company is a blank check company targeting acquisitions, specifically focusing on the national security or defense-related industries.

Capital needs remain high with $2.6 million in cash as of December 2025, down from a working capital deficit previously.

Discontinuing memory IC products drastically reduced revenues from 89 percent down to 22 percent. Going concern risk persists with cash of $2.9 million lasting into the third quarter of 2026. Evaluating an acquisition proposal from Mobix Labs introduces strategic alternative risks.

The company added disclosures on 45Z production tax credits and updated its figures on ethanol exports and domestic production capacity. It also updated ongoing tax examinations and carbon sequestration regulations.

RenovoCath generated $1.1 million in 2025, but commercialization remains limited and the company still reported an $11.2 million net loss.

The company faces a Nasdaq minimum bid price deficiency notice, threatening delisting of its common stock. Insider ownership concentration decreased significantly from 34.16% to 12.7%.

Socket Mobile removed its deferred tax asset risk while updating share count and stock price range figures.

Capital requirements and ongoing clinical trial expenses dominate the new risk disclosures.

Aptera faces severe going concern doubts, zero commercial production of its three-wheeled solar vehicles, and no revenue to date. The company is actively consuming capital and relies heavily on future equity and debt financing. Legal risks include an ongoing SEC investigation and a patent infringement lawsuit.

Expanding into new products like Siebert Crypto and investment banking risks straining management resources and internal controls. The public float held by non-affiliates increased to 14,441,440 shares, or approximately 35.3%. Material weaknesses regarding IT controls were removed from the risk section.

HPC and AI expansion adds execution, technology, equipment, supply-chain and trade-policy risks.